Acadia Pharmaceuticals ACAD
NASDAQ ACAD
$19.73 -0.58 (-2.86%)
At close: Oct 23, 2026 · 4:00 PM EDT

Acadia Pharmaceuticals (ACAD) Gains from Sales and Divestitures (2013 - 2018)

Updated

Acadia Pharmaceuticals' Gains from Sales and Divestitures was $146.52 million in FY2024.

Analysis

Acadia Pharmaceuticals (ACAD) Gains from Sales and Divestitures (2013 - 2018) Analysis & Trends

From FY2010 onward, Acadia Pharmaceuticals has reported Gains from Sales and Divestitures for 9 years.

  • The FY2024 figure marks the highest annual Gains from Sales and Divestitures in data going back to FY2010.
  • Per Business Quant data, Gains from Sales and Divestitures in earlier years was -$281,000 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Acadia Pharmaceuticals 3.39 Bn -84.62 Mn 279.64 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 -61,000.00
Sep 30, 2018 5,000.00
Jun 30, 2018 -23,000.00
Mar 31, 2018 -9,000.00
Mar 31, 2016 -5,000.00
Sep 30, 2013 -1,000.00
API Access

Acadia Pharmaceuticals Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=ACAD&period=max&api_key=YOUR_API_KEY